The FDA is exploring a partnership with OpenAI to accelerate the drug approval process through artificial intelligence, potentially transforming how new medications reach patients. This initiative represents a significant shift in regulatory technology application, as the FDA commissioner recently revealed the agency has already completed its first AI-assisted scientific review and is actively pursuing further AI integration to address the decade-long timeline typically required for new drugs to reach the market.
The big picture: FDA commissioner Marty Makary has publicly questioned the lengthy drug approval process and signaled the agency’s commitment to modernization through artificial intelligence.
- Makary wrote on social media: “Why does it take over 10 years for a new drug to come to market? Why are we not modernized with AI and other things? We’ve just completed our first AI-assisted scientific review for a product and that’s just the beginning.”
- The commissioner discussed AI’s potential to accelerate approvals for diabetes treatments and certain cancer therapies during an American Hospital Association meeting.
Behind the scenes: OpenAI representatives have held multiple meetings with FDA officials and associates from Elon Musk‘s Department of Government Efficiency.
- The discussions center around a project tentatively called cderGPT, likely referencing the FDA’s Center for Drug Evaluation and Research.
- Jeremy Walsh, recently appointed as the FDA’s first AI officer, is leading these discussions with OpenAI.
Where things stand: Despite ongoing meetings between OpenAI and the FDA, no formal contract has been signed yet.
- OpenAI has declined to comment on the potential partnership or the nature of the discussions.
- The initiative appears to be in early exploratory stages, with multiple stakeholders involved in shaping the potential collaboration.
Why this matters: Implementing AI in the drug approval process could significantly reduce the time required to bring life-saving medications to market, potentially benefiting millions of patients waiting for new treatments.
Recent Stories
DOE fusion roadmap targets 2030s commercial deployment as AI drives $9B investment
The Department of Energy has released a new roadmap targeting commercial-scale fusion power deployment by the mid-2030s, though the plan lacks specific funding commitments and relies on scientific breakthroughs that have eluded researchers for decades. The strategy emphasizes public-private partnerships and positions AI as both a research tool and motivation for developing fusion energy to meet data centers' growing electricity demands. The big picture: The DOE's roadmap aims to "deliver the public infrastructure that supports the fusion private sector scale up in the 2030s," but acknowledges it cannot commit to specific funding levels and remains subject to Congressional appropriations. Why...
Oct 17, 2025Tying it all together: Credo’s purple cables power the $4B AI data center boom
Credo, a Silicon Valley semiconductor company specializing in data center cables and chips, has seen its stock price more than double this year to $143.61, following a 245% surge in 2024. The company's signature purple cables, which cost between $300-$500 each, have become essential infrastructure for AI data centers, positioning Credo to capitalize on the trillion-dollar AI infrastructure expansion as hyperscalers like Amazon, Microsoft, and Elon Musk's xAI rapidly build out massive computing facilities. What you should know: Credo's active electrical cables (AECs) are becoming indispensable for connecting the massive GPU clusters required for AI training and inference. The company...
Oct 17, 2025Vatican launches Latin American AI network for human development
The Vatican hosted a two-day conference bringing together 50 global experts to explore how artificial intelligence can advance peace, social justice, and human development. The event launched the Latin American AI Network for Integral Human Development and established principles for ethical AI governance that prioritize human dignity over technological advancement. What you should know: The Pontifical Academy of Social Sciences, the Vatican's research body for social issues, organized the "Digital Rerum Novarum" conference on October 16-17, combining academic research with practical AI applications. Participants included leading experts from MIT, Microsoft, Columbia University, the UN, and major European institutions. The conference...